ROK
62
15
CTSH
56
2
VMC
57
4
URI
65
5
RL
72
4
ADT
53
3
YUM
47
3
R
71
4
DFS
64
2
NOC
43
11
DRI
53
5
EBAY
47
4
UPS
60
9
EQIX
64
2
BBY
46
10
KMI
67
-2
AON
54
2
MRK
25
-2
CCI
31
3
F
58
11
ROK
62
15
CTSH
56
2
VMC
57
4
URI
65
5
RL
72
4
ADT
53
3
YUM
47
3
R
71
4
DFS
64
2
NOC
43
11
DRI
53
5
EBAY
47
4
UPS
60
9
EQIX
64
2
BBY
46
10
KMI
67
-2
AON
54
2
MRK
25
-2
CCI
31
3
F
58
11
Financhill
Back

Evolus Vs. Perspective Therapeutics Industry Stock Comparison

Sell
22

EOLS
Evolus

Last Price:
12.61
Seasonality Move:
73.77%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
22
Evolus (EOLS) is a Sell

Is Evolus a Buy, Sell or Hold?

  • The current Evolus [EOLS] share price is $12.60. The Score for EOLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • EOLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EOLS Stock Price Chart

What is Evolus's stock price today?

  • The Evolus share price today is $12.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EOLS is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

EOLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.02 Sell
Relative Strength Index (14 RSI): 35.61 Sell
Chaikin Money Flow: -504185 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.69 - 16.51) Sell
Bollinger Bands (100): (12.59 - 16.55) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

EOLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.36 Buy
20-day SMA: 14.25 Sell
50-day SMA: 15.6 Sell
200-day SMA: 13.71 Sell
8-day EMA: 12.77 Sell
20-day EMA: 13.78 Sell
50-day EMA: 14.71 Sell
200-day EMA: 13.58 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Evolus Earnings Growth & EOLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.34 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Evolus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):